Peptidomimetics Based on C-Terminus of Blm10 Stimulate Human 20S Proteasome Activity and Promote Degradation of Proteins
Biomolecules (2022), 12, 777. DOI: 10.3390/biom12060777
Cognitive function correlates with gastric alpha-synuclein seeding activity in early Parkinson’s disease
NPJ Parkinsons Dis. 11, 311 (2025). DOI: 10.1038/s41531-025-01152-3
PET-MRI biomarkers reveal efficacy of a novel NLRP3 2 inhibitor in Parkinson’s disease models
Oxford Academic, Brain, (2025). DOI: 10.1093/brain/awaf372
Dendritic Cells Induce Clec5a-mediated Immune Modulation in MPTP-induced Parkinson’s Disease Mouse Model
Front. Biosci. (Landmark Ed) 2025, 30(8), 39570; DOI: 10.31083/FBL39570
In Vitro Evaluation of Amide-Linked Coumarin Scaffolds for the Inhibition of α-Synuclein and Tau Aggregation
ACS Omega 2025, XXXX, XXX, XXX-XXX, DOI: 10.1021/acsomega.5c02435
Physical and Mechanical Properties of Monomeric Alpha-Synuclein Provide Leads to Molecular Function
J. Phys. Chem. B 2025, 129, 33, 8351–8359 DOI: 10.1021/acs.jpcb.5c03200
Perilla-derived chalcone inhibits α-synuclein fibrillization and prevents aggregate-induced disruption of intracellular α-synuclein conformation in neuronal cells
Science Direct (2025) (779), DOI: 10.1016/j.bbrc.2025.152452.
Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson’s disease
Nat Commun 16, 6630 (2025). DOI: 10.1038/s41467-025-61052-1
α-Synuclein fibrils enhance HIV-1 infection of human T cells, macrophages and microglia
Nat Commun 16, 813 (2025). DOI: 10.1038/s41467-025-56099-z
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's disease
Alzheimers Dement (2025) 21 (4), e70146 DOI: 10.1002/alz.70146